Data as of Mar 07
| +0.27 / +0.49%|
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 65.00 and a low estimate of 29.00. The median estimate represents a +7.47% increase from the last price of 55.83.
The current consensus among 22 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.